The optimal cutoff value of BCAA was 63.96 μg/mL, with 65.27% sensitivity and 72.34% specificity, suggesting that men with plasma BCAA level higher than 63.96 μg/mL were more likely to have CHD (Table 2). The gene discussed is ARID4B; the disease is coronary artery disorder.